UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy

Technology in Cancer Research & Treatment, 2018-01, Vol.17, p.1533033818801809-1533033818801809

2018

Volltextzugriff (PDF)

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer

Journal of cancer research and clinical oncology, 2020-03, Vol.146 (3), p.631-645

2020

Volltextzugriff (PDF)

Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2331273-2331273

2024

Volltextzugriff (PDF)

hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

Cell death & disease, 2021-08, Vol.12 (9), p.807-807, Article 807

2021

Volltextzugriff (PDF)

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways

Chinese medical journal, 2023-11, Vol.136 (22), p.2712-2721

2023

Volltextzugriff (PDF)

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Cellular & molecular immunology, 2021-02, Vol.18 (2), p.427-439

2021

Volltextzugriff (PDF)

Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient

Cancer Immunology, Immunotherapy, 2021-08, Vol.70 (8), p.2261-2274

2021

Volltextzugriff (PDF)

Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient

Cancer Immunology, Immunotherapy, 2021-08, Vol.70 (8), p.2261-2274

2021

Volltextzugriff (PDF)

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

The Annals of thoracic surgery, 2016-03, Vol.101 (3), p.1145-1152

2016

Volltextzugriff (PDF)

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

Journal of international medical research, 2020-04, Vol.48 (4), p.300060519887275-300060519887275

2020

Volltextzugriff (PDF)

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

The New England journal of medicine, 2009-09, Vol.361 (10), p.947-957

2009

Volltextzugriff (PDF)

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study

The oncologist (Dayton, Ohio), 2019-02, Vol.24 (2), p.157-e64

2019

Volltextzugriff (PDF)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting

Frontiers in oncology, 2022-06, Vol.12, p.785865-785865

2022

Volltextzugriff (PDF)

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Diagnosing Intrathoracic Tuberculosis

The Annals of thoracic surgery, 2013-12, Vol.96 (6), p.2021-2027

2013

Volltextzugriff (PDF)

Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients

PloS one, 2012-03, Vol.7 (3), p.e33200-e33200

2012

Volltextzugriff (PDF)

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2011-10, Vol.60 (10), p.1497-1502

2011

Volltextzugriff (PDF)

Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis

Cell death & disease, 2021-02, Vol.12 (2), p.170-14, Article 170

2021

Volltextzugriff (PDF)

Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib

Journal of cancer research and clinical oncology, 2020-02, Vol.146 (2), p.401-406

2020

Volltextzugriff (PDF)

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

PLoS genetics, 2016-04, Vol.12 (4), p.e1005895-e1005895

2016

Volltextzugriff (PDF)

Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management

European journal of cardio-thoracic surgery, 2022-07, Vol.62 (2)

2022

Volltextzugriff (PDF)

Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR

PloS one, 2013-12, Vol.8 (12), p.e80458-e80458

2013

Volltextzugriff (PDF)

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

The lancet oncology, 2012-05, Vol.13 (5), p.466-475

2012

Volltextzugriff (PDF)

Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer

Cancer medicine (Malden, MA), 2023-03, Vol.12 (5), p.5372-5383

2023

Volltextzugriff (PDF)

Prognostic role of serum cytokines level in non-small cell lung cancer patients with anti-PD-1 and chemotherapy combined treatment

Frontiers in immunology, 2024-10, Vol.15

2024

Volltextzugriff (PDF)

1 – 25 von 607

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(539)
Mit Volltextzugriff
(573)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(394)
Life Sciences & Biomedicine
(349)
Oncology
(241)
Humans
(232)
Lung Cancer
(208)
Male
(149)
Female
(143)
Middle Aged
(131)
Aged
(115)
Lung Neoplasms - Drug Therapy
(111)
Lung Neoplasms - Pathology
(101)
Chemotherapy
(100)
Adult
(95)
Lung Neoplasms - Genetics
(92)
Mutation
(87)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(83)
Respiratory System
(83)
Cancer Therapies
(68)
Prognosis
(66)
Non-Small Cell Lung Cancer
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Zhongguo Fei Ai Za Zhi
(72)
Journal Of Clinical Oncology
(48)
Journal Of Thoracic Oncology
(24)
Thoracic Cancer
(21)
Lung Cancer
(18)
Oncotarget
(13)
Frontiers In Oncology
(12)
Journal Of Cancer Research And Clinical Oncology
(11)
Tumor Biology
(10)
Clinical Lung Cancer
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer

Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer

hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient

Single-cell RNA sequencing reveals cellular and molecular immune profile in a Pembrolizumab-responsive PD-L1-negative lung cancer patient

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Diagnosing Intrathoracic Tuberculosis

Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis

Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management

Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

Efficacy and safety of anlotinib combined with PD‐1/PD‐L1 inhibitors as second‐line and subsequent therapy in advanced small‐cell lung cancer

Prognostic role of serum cytokines level in non-small cell lung cancer patients with anti-PD-1 and chemotherapy combined treatment

A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese

Suchergebnisse filtern